About Signova Pharma
Signova Pharma is a company. The company has 421 employees as of April 07, 2024. Signova Pharma offers products and services including Rabsig DSR and Raxclav 625.
- Employees 421 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Signova Pharma Pvt. Ltd
- Jurisdiction Guwahati, Assam, India
-
Annual Revenue
$13.6 M (USD)0as on Mar 31, 2023
-
Net Profit
$720.42 K (USD)0as on Mar 31, 2023
-
EBITDA
$1.09 M (USD)0as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
421
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Signova Pharma
Signova Pharma offers a comprehensive portfolio of products and services, including Rabsig DSR and Raxclav 625.
This product is provided as part of the company's range aimed at delivering safe and efficacious healthcare solutions.
This product is included among the offerings that are updated with the latest molecules to support quality healthcare.
Funding Insights of Signova Pharma
Detailed funding history for Signova Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Signova Pharma
Investment portfolio details for Signova Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Signova Pharma
Detailed financials for Signova Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Signova Pharma Comparisons
Peer comparison for Signova Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Signova Pharma
Detailed competitors of Signova Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Signova Pharma
Complete news archive for Signova Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Signova Pharma
As of Apr 07, 2024, the latest employee count at Signova Pharma is 421.
Annual revenue of Signova Pharma is $13.6M as on Mar 31, 2023.
Signova Pharma has been established since January 2008, where consistent efforts are made to pursue excellence in healthcare services through the development of safe and efficacious products. The companys range is updated regularly with the latest molecules to foster a healthy society, as initiatives are taken for sustainable growth and a strong industry position. Valuable efforts are directed towards serving humanity and providing quality pharmaceutical offerings across 26 categories, ensuring multi-lateral growth is achieved without promotional emphasis.
Signova Pharma offers Rabsig DSR and Raxclav 625.